268 related articles for article (PubMed ID: 16206189)
1. ABCB1 over-expression and drug-efflux in acute lymphoblastic leukemia cell lines with t(17;19) and E2A-HLF expression.
Baudis M; Prima V; Tung YH; Hunger SP
Pediatr Blood Cancer; 2006 Nov; 47(6):757-64. PubMed ID: 16206189
[TBL] [Abstract][Full Text] [Related]
2. E4BP4 expression is regulated by the t(17;19)-associated oncoprotein E2A-HLF in pro-B cells.
Yeung J; O'Sullivan E; Hubank M; Brady HJ
Br J Haematol; 2004 Jun; 125(5):560-7. PubMed ID: 15147370
[TBL] [Abstract][Full Text] [Related]
3. Oncogenic fusion E2A-HLF sensitizes t(17;19)-positive acute lymphoblastic leukemia to TRAIL-mediated apoptosis by upregulating the expression of death receptors.
Zhang X; Inukai T; Hirose K; Akahane K; Kuroda I; Honna-Oshiro H; Kagami K; Goi K; Nakamura K; Kobayashi M; Endo M; Yagita H; Kurosawa H; Thomas Look A; Honda H; Inaba T; Nakazawa S; Sugita K
Leukemia; 2012 Dec; 26(12):2483-93. PubMed ID: 22743623
[TBL] [Abstract][Full Text] [Related]
4. Characterization of the t(17;19) translocation by gene-specific fluorescent in situ hybridization-based cytogenetics and detection of the E2A-HLF fusion transcript and protein in patients' cells.
Yeung J; Kempski H; Neat M; Bailey S; Smith O; Brady HJ
Haematologica; 2006 Mar; 91(3):422-4. PubMed ID: 16531271
[TBL] [Abstract][Full Text] [Related]
5. Identification of Zfp521/ZNF521 as a cooperative gene for E2A-HLF to develop acute B-lineage leukemia.
Yamasaki N; Miyazaki K; Nagamachi A; Koller R; Oda H; Miyazaki M; Sasaki T; Honda ZI; Wolff L; Inaba T; Honda H
Oncogene; 2010 Apr; 29(13):1963-75. PubMed ID: 20062079
[TBL] [Abstract][Full Text] [Related]
6. The effects of siRNA-mediated inhibition of E2A-PBX1 on EB-1 and Wnt16b expression in the 697 pre-B leukemia cell line.
Casagrande G; te Kronnie G; Basso G
Haematologica; 2006 Jun; 91(6):765-71. PubMed ID: 16769578
[TBL] [Abstract][Full Text] [Related]
7. Aberrant induction of LMO2 by the E2A-HLF chimeric transcription factor and its implication in leukemogenesis of B-precursor ALL with t(17;19).
Hirose K; Inukai T; Kikuchi J; Furukawa Y; Ikawa T; Kawamoto H; Oram SH; Göttgens B; Kiyokawa N; Miyagawa Y; Okita H; Akahane K; Zhang X; Kuroda I; Honna H; Kagami K; Goi K; Kurosawa H; Look AT; Matsui H; Inaba T; Sugita K
Blood; 2010 Aug; 116(6):962-70. PubMed ID: 20519628
[TBL] [Abstract][Full Text] [Related]
8. Different patterns of homozygous p16INK4A and p15INK4B deletions in childhood acute lymphoblastic leukemias containing distinct E2A translocations.
Maloney KW; McGavran L; Odom LF; Hunger SP
Leukemia; 1998 Sep; 12(9):1417-21. PubMed ID: 9737691
[TBL] [Abstract][Full Text] [Related]
9. DNA-binding and transcriptional regulatory properties of hepatic leukemia factor (HLF) and the t(17;19) acute lymphoblastic leukemia chimera E2A-HLF.
Hunger SP; Brown R; Cleary ML
Mol Cell Biol; 1994 Sep; 14(9):5986-96. PubMed ID: 8065331
[TBL] [Abstract][Full Text] [Related]
10. Expression levels of TEL, AML1, and the fusion products TEL-AML1 and AML1-TEL versus drug sensitivity and clinical outcome in t(12;21)-positive pediatric acute lymphoblastic leukemia.
Stams WA; den Boer ML; Beverloo HB; Meijerink JP; van Wering ER; Janka-Schaub GE; Pieters R
Clin Cancer Res; 2005 Apr; 11(8):2974-80. PubMed ID: 15837750
[TBL] [Abstract][Full Text] [Related]
11. Reversal of apoptosis by the leukaemia-associated E2A-HLF chimaeric transcription factor.
Inaba T; Inukai T; Yoshihara T; Seyschab H; Ashmun RA; Canman CE; Laken SJ; Kastan MB; Look AT
Nature; 1996 Aug; 382(6591):541-4. PubMed ID: 8700228
[TBL] [Abstract][Full Text] [Related]
12. beta-catenin is involved in N-cadherin-dependent adhesion, but not in canonical Wnt signaling in E2A-PBX1-positive B acute lymphoblastic leukemia cells.
Nygren MK; Døsen-Dahl G; Stubberud H; Wälchli S; Munthe E; Rian E
Exp Hematol; 2009 Feb; 37(2):225-33. PubMed ID: 19101069
[TBL] [Abstract][Full Text] [Related]
13. Characterisation of genomic translocation breakpoints and identification of an alternative TCF3/PBX1 fusion transcript in t(1;19)(q23;p13)-positive acute lymphoblastic leukaemias.
Paulsson K; Jonson T; Ora I; Olofsson T; Panagopoulos I; Johansson B
Br J Haematol; 2007 Jul; 138(2):196-201. PubMed ID: 17593026
[TBL] [Abstract][Full Text] [Related]
14. The proto-oncogene HLF and the related basic leucine zipper protein TEF display highly similar DNA-binding and transcriptional regulatory properties.
Hunger SP; Li S; Fall MZ; Naumovski L; Cleary ML
Blood; 1996 Jun; 87(11):4607-17. PubMed ID: 8639829
[TBL] [Abstract][Full Text] [Related]
15. The E2A-HLF oncogenic fusion protein acts through Lmo2 and Bcl-2 to immortalize hematopoietic progenitors.
de Boer J; Yeung J; Ellu J; Ramanujachar R; Bornhauser B; Solarska O; Hubank M; Williams O; Brady HJ
Leukemia; 2011 Feb; 25(2):321-30. PubMed ID: 21072044
[TBL] [Abstract][Full Text] [Related]
16. Expression of identical E2A/PBX1 fusion transcripts occurs in both pre-B and early pre-B immunological subtypes of childhood acute lymphoblastic leukemia.
Izraeli S; Henn T; Strobl H; Ludwig WD; Kovar H; Haas OA; Harbott J; Bartram CR; Gadner H; Lion T
Leukemia; 1993 Dec; 7(12):2054-6. PubMed ID: 8255105
[TBL] [Abstract][Full Text] [Related]
17. E2A/HLF fusion cDNAs and the use of RT-PCR for the detection of minimal residual disease in t(17;19)(q22;p13) acute lymphoblastic leukemia.
Devaraj PE; Foroni L; Sekhar M; Butler T; Wright F; Mehta A; Samson D; Prentice HG; Hoffbrand AV; Secker-Walker LM
Leukemia; 1994 Jul; 8(7):1131-8. PubMed ID: 7518549
[TBL] [Abstract][Full Text] [Related]
18. Specific induction of CD33 expression by E2A-HLF: the first evidence for aberrant myeloid antigen expression in ALL by a fusion transcription factor.
Akahane K; Inukai T; Inaba T; Kurosawa H; Look AT; Kiyokawa N; Fujimoto J; Goto H; Endo M; Zhang X; Hirose K; Kuroda I; Honna H; Kagami K; Goi K; Nakazawa S; Sugita K
Leukemia; 2010 Apr; 24(4):865-9. PubMed ID: 20147975
[No Abstract] [Full Text] [Related]
19. DNA-binding specificity and trans-activating potential of the leukemia-associated E2A-hepatic leukemia factor fusion protein.
Inaba T; Shapiro LH; Funabiki T; Sinclair AE; Jones BG; Ashmun RA; Look AT
Mol Cell Biol; 1994 May; 14(5):3403-13. PubMed ID: 8164688
[TBL] [Abstract][Full Text] [Related]
20. [Childhood acute lymphoblastic leukemia with t(1;19) lacking E2A-pBX1 chimeric transcripts].
Matsubara K; Hirata T
Rinsho Ketsueki; 2005 Jan; 46(1):7-12. PubMed ID: 16708911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
